US Patent 6875434 Methods of treatment of Alzheimer's disease
Patent 6875434 was granted and assigned to Neuralab on April, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+492 characters)
Article
Patent abstract
Disclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disesase, prion diseases, familial amyloid neuropathies and the like. The pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, particularly fibril-forming peptides or proteins. Also disclosed are therapeutic compositions and methods which use immune reagents that react with such fibril components.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Dale B. Schenk0
Date of Patent
April 5, 2005
0Patent Application Number
097249530
Date Filed
November 28, 2000
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6875434 Methods of treatment of Alzheimer's disease
Find more entities like US Patent 6875434 Methods of treatment of Alzheimer's disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
